Analyst Consensus ?
ConsensusBuy69 ratings
Bullish6087.0%
Neutral811.6%
Bearish11.4%
ServiceNow, Inc. · NOW · FY2026 Q2 · Calendar Q3 2026
ServiceNow Q2 2026: AI ACV Crosses $1B as Cybersecurity Hits $1B Run Rate
ServiceNow's Q2 2026 results reinforce its transition from a workflow automation platform into an AI-driven enterprise operating system. Subscription revenue grew 23% YoY to $3.877 billion with a 29.5% operating margin, beating the high end of guidance. AI ACV crossed the $1 billion milestone and cybersecurity reached a $1 billion run rate, validating the acquisition strategy behind Armis and Moveworks. Management raised full-year guidance and expressed confidence in sustained AI-driven demand, though margin dynamics from consumption-based pricing and integration costs remain the key watch items.
Reported After market closeNYSETechnology
$109.13B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.90
Consensus $0.86
EPS surprise
+4.7%
Reported versus consensus
Reported revenue
$3.99B
Consensus $3.93B
Revenue surprise
+1.5%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-3.7%
Event window
SPY move
-1.2%
Same window
Abnormal move
-2.5%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
+20.3%
Up to 20 sessions
NOWSPY benchmark
Ask FN2 about NOW FY2026 Q2
Transcript, numbers and history already loaded
Why did NOW fall 3.7% after beating EPS estimates in FY2026 Q2?What changed in NOW's guidance and outlook in FY2026 Q2?Give me the bull and bear case for NOW after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
In Q2 2026, ServiceNow reported subscription revenue of $3.877 billion, up 23% YoY, beating the high end of guidance. Operating margin came in at 29.5%. AI ACV surpassed $1 billion, on track for the $1.5 billion year-end target, with management projecting AI will represent 30% of ACV by 2030. The cybersecurity segment, bolstered by the Armis acquisition, reached a $1 billion run rate, making ServiceNow the fastest-growing company among the top ten enterprise cyber firms. Full-year subscription revenue guidance was raised modestly. The stock's initial reaction was negative with a 2.45% abnormal decline the session after the report, but shares subsequently rallied over 20% to $110.62 as of July 28.
Guidance delta
Management raised full-year 2026 subscription revenue guidance modestly, building on the Q1 raise of $205 million that brought the range to $15.735-$15.775 billion. AI ACV is tracking toward the $1.5 billion year-end target. Guidance sentiment is raised, consistent with the prior quarter's upward revision.
Key takeaways
- Q2 subscription revenue of $3.877 billion grew 23% YoY, beating the high end of guidance with a 29.5% operating margin.
- AI ACV surpassed $1 billion, on track for $1.5 billion by year-end; management expects AI to represent 30% of ACV by 2030.
- Cybersecurity is now a $1 billion business, making ServiceNow the fastest-growing company among the top ten enterprise cyber firms.
- Full-year subscription revenue guidance was raised modestly, reflecting continued confidence in AI-driven demand.
- An upcoming AI-native conversational service desk product will eliminate tickets and use AI-coded automation, targeting the Fortune 500,000 market.
Management priorities
- Launch an AI-native conversational service desk with no-ticket workflow.
- Expand AI specialist headcount and broaden AI Control Tower capabilities.
- Deepen integration with Microsoft Agent 365, NVIDIA Open Shell, and Accenture.
- Continue acquisition strategy to bolster security and AI capabilities.
- Target broader enterprise segments, including the Fortune 500,000.
Follow NOW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$158.18Previous close
$85Low
$158.94Average
$266High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | Buy | Maintain | Oct 23, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 21, 2026 |
| StoneX | Buy | Buy | Maintain | Oct 19, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 16, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 15, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 13, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 12, 2026 |
| BTIG | Buy | Buy | Maintain | Oct 12, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 6, 2026 |
| Stifel | Buy | Buy | Maintain | Oct 6, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Sep 21, 2026 |
| Needham | Buy | Buy | Maintain | Sep 11, 2026 |
| B of A Securities | Buy | Buy | Maintain | Aug 19, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Jul 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 23, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 23, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 20, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 9, 2026 |
| Benchmark | Buy | Buy | Maintain | Jun 15, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | May 5, 2026 |
| Keybanc | Underweight | Underweight | Maintain | Apr 23, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Apr 23, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 16, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Sep 24, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 4, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 24, 2025 |
| TD Securities | Buy | Buy | Maintain | Apr 24, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 24, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 11, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | May 10, 2024 |
| MoffettNathanson | Outperform | Outperform | Maintain | Jul 27, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 27, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 26, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jun 24, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 8, 2019 |
| CFRA | Buy | Hold | Upgrade | Nov 4, 2019 |
| Atlantic Equities | Neutral | Neutral | Maintain | Jan 9, 2019 |
| Bank of America | Buy | Buy | Maintain | Jul 25, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| Summit Redstone Partners | Buy | Buy | Maintain | Sep 18, 2017 |
| Stephens & Co. | Overweight | Overweight | Maintain | May 25, 2017 |
| Wunderlich | Buy | Buy | Maintain | Oct 27, 2016 |
| Wunderlich Securities | Buy | Buy | Maintain | Oct 26, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Jul 28, 2016 |
| Argus | Buy | Buy | Maintain | Apr 14, 2016 |
| BTIG Research | Buy | Buy | Maintain | Sep 10, 2015 |
| MKM Partners | Buy | Buy | Maintain | Jun 9, 2015 |
| Brean Capital | Buy | Buy | Maintain | Mar 17, 2015 |
| William Blair | Outperform | Outperform | Maintain | Sep 15, 2014 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2014 |
| B. Riley | Neutral | Neutral | Maintain | Apr 24, 2014 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Apr 4, 2014 |
| Janney Capital | Neutral | Neutral | Maintain | Oct 8, 2013 |
| Northland Securities | Outperform | Market Perform | Upgrade | Oct 4, 2013 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Oct 4, 2013 |
| JG Capital | Neutral | Overweight | Downgrade | Aug 1, 2013 |
| Susquehanna | Outperform | Positive | Maintain | Jul 16, 2013 |
| Maxim Group | Buy | Buy | Maintain | Apr 2, 2013 |
| FBN Securities | Outperform | Outperform | Maintain | Mar 20, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $158.18. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Analyst unavailable | $175 | $157 | +10.6% | Oct 23, 2026 |
| Truist Financial | Analyst unavailable | $180 | $149.54 | +13.8% | Oct 21, 2026 |
| Bernstein | Analyst unavailable | $266 | $145.36 | +68.2% | Oct 20, 2026 |
| UBS | Analyst unavailable | $165 | $141.97 | +4.3% | Oct 19, 2026 |
| Piper Sandler | Analyst unavailable | $175 | $148.57 | +10.6% | Oct 16, 2026 |
| Mizuho Securities | Analyst unavailable | $170 | $139.98 | +7.5% | Oct 15, 2026 |
| Oppenheimer | Brian Schwartz | $165 | $140.32 | +4.3% | Oct 13, 2026 |
| Barclays | Analyst unavailable | $160 | $140.32 | +1.2% | Oct 13, 2026 |
| RBC Capital | Analyst unavailable | $176 | $144.01 | +11.3% | Oct 12, 2026 |
| Wells Fargo | Analyst unavailable | $190 | $140.86 | +20.1% | Oct 12, 2026 |
| Stifel Nicolaus | Brad Reback | $160 | $136.08 | +1.2% | Oct 6, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $174 | $135.47 | +10.0% | Sep 21, 2026 |
| Needham | Mike Cikos | $155 | $131.17 | -2.0% | Sep 11, 2026 |
| BTIG | Analyst unavailable | $170 | $141.26 | +7.5% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $175 | $127.54 | +10.6% | Aug 12, 2026 |
| BMO Capital | Analyst unavailable | $118 | $97.33 | -25.4% | Jul 23, 2026 |
| Evercore ISI | Kirk Materne | $160 | $96.74 | +1.2% | Jul 23, 2026 |
| UBS | Analyst unavailable | $110 | $95.46 | -30.5% | Jul 23, 2026 |
| UBS | Analyst unavailable | $248 | $95.46 | +56.8% | Jul 23, 2026 |
| UBS | Analyst unavailable | $157 | $95.46 | -0.7% | Jul 23, 2026 |
| Jefferies | Samad Samana | $140 | $95.46 | -11.5% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $102.91 | +13.8% | Jul 21, 2026 |
| D.A. Davidson | Gil Luria | $170 | $103.24 | +7.5% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $130 | $100.22 | -17.8% | Jul 16, 2026 |
| Oppenheimer | Brian Schwartz | $140 | $104.85 | -11.5% | Jul 15, 2026 |
| Truist Financial | Analyst unavailable | $130 | $107.78 | -17.8% | Jul 9, 2026 |
| Goldman Sachs | Gabriela Borges | $145 | $107.78 | -8.3% | Jul 8, 2026 |
| Guggenheim | Analyst unavailable | $125 | $99.28 | -21.0% | Jul 1, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $130 | $105.78 | -17.8% | Jun 15, 2026 |
| Bernstein | Peter Weed | $236 | $92.01 | +49.2% | May 6, 2026 |
| Evercore ISI | Kirk Materne | $150 | $90.74 | -5.2% | May 5, 2026 |
| Barclays | Analyst unavailable | $134 | $91.97 | -15.3% | May 5, 2026 |
| Wolfe Research | Analyst unavailable | $125 | $84.68 | -21.0% | Apr 23, 2026 |
| Barclays | Raimo Lenschow | $132 | $86.31 | -16.6% | Apr 23, 2026 |
| UBS | Analyst unavailable | $120 | $86.26 | -24.1% | Apr 23, 2026 |
| Stifel Nicolaus | Brad Reback | $120 | $88.17 | -24.1% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $115 | $87.9 | -27.3% | Apr 23, 2026 |
| UBS | Analyst unavailable | $150 | $103.07 | -5.2% | Apr 23, 2026 |
| Needham | Analyst unavailable | $115 | $103.07 | -27.3% | Apr 23, 2026 |
| Goldman Sachs | Analyst unavailable | $163 | $103.07 | +3.0% | Apr 23, 2026 |
| Piper Sandler | Analyst unavailable | $140 | $103.07 | -11.5% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $118 | $103.07 | -25.4% | Apr 23, 2026 |
| KeyBanc | Analyst unavailable | $85 | $103.07 | -46.3% | Apr 23, 2026 |
| Jefferies | Samad Samana | $135 | $103.07 | -14.7% | Apr 23, 2026 |
| Deutsche Bank | Analyst unavailable | $135 | $96.06 | -14.7% | Apr 16, 2026 |
| Robert W. Baird | Analyst unavailable | $125 | $94.19 | -21.0% | Apr 16, 2026 |
| Truist Financial | Analyst unavailable | $125 | $93.86 | -21.0% | Apr 15, 2026 |
| Oppenheimer | Analyst unavailable | $130 | $87.79 | -17.8% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $150 | $89.06 | -5.2% | Apr 14, 2026 |
| UBS | Analyst unavailable | $100 | $82.5 | -36.8% | Apr 10, 2026 |
| Truist Financial | Analyst unavailable | $175 | $106.8 | +10.6% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $216 | $117.01 | +36.6% | Feb 2, 2026 |
| D.A. Davidson | Gil Luria | $220 | $113.76 | +39.1% | Jan 29, 2026 |
| Deutsche Bank | Analyst unavailable | $180 | $115.91 | +13.8% | Jan 29, 2026 |
| RBC Capital | Analyst unavailable | $185 | $114.9 | +17.0% | Jan 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $180 | $115.29 | +13.8% | Jan 29, 2026 |
| BMO Capital | Keith Bachman | $170 | $114.92 | +7.5% | Jan 29, 2026 |
| Evercore ISI | Kirk Materne | $175 | $114.64 | +10.6% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $175 | $115.16 | +10.6% | Jan 29, 2026 |
| KeyBanc | Jackson Ader | $115 | $114.16 | -27.3% | Jan 29, 2026 |
| Canaccord Genuity | Analyst unavailable | $200 | $129.62 | +26.4% | Jan 29, 2026 |
| UBS | Analyst unavailable | $195 | $115.65 | +23.3% | Jan 29, 2026 |
| UBS | Analyst unavailable | $115 | $129.62 | -27.3% | Jan 29, 2026 |
| BMO Capital | Keith Bachman | $175 | $124.2 | +10.6% | Jan 21, 2026 |
| Oppenheimer | Analyst unavailable | $175 | $125.4 | +10.6% | Jan 21, 2026 |
| UBS | Analyst unavailable | $175 | $127.54 | +10.6% | Jan 21, 2026 |
| Mizuho Securities | Analyst unavailable | $190 | $125.4 | +20.1% | Jan 21, 2026 |
| UBS | Karl Keirstead | $260 | $127.38 | +64.4% | Jan 20, 2026 |
| Goldman Sachs | Analyst unavailable | $205 | $141.8 | +29.6% | Jan 12, 2026 |
| Stifel Nicolaus | Brad Reback | $200 | $142.42 | +26.4% | Jan 9, 2026 |
| Wells Fargo | Analyst unavailable | $225 | $150.9 | +42.2% | Jan 8, 2026 |
| Arete Research | Analyst unavailable | $200 | $147.6 | +26.4% | Jan 6, 2026 |
| Piper Sandler | Rob Owens | $200 | $147.45 | +26.4% | Jan 5, 2026 |
| RBC Capital | Matthew Hedberg | $195 | $147.45 | +23.3% | Jan 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $230 | $153.65 | +45.4% | Dec 19, 2025 |
| Oppenheimer | Brian Schwartz | $230 | $152.95 | +45.4% | Dec 18, 2025 |
| BTIG | Analyst unavailable | $200 | $156.22 | +26.4% | Dec 16, 2025 |
| D.A. Davidson | Analyst unavailable | $220 | $154.44 | +39.1% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $210 | $155.19 | +32.8% | Dec 16, 2025 |
| KeyBanc | Jackson Ader | $155 | $173 | -2.0% | Dec 15, 2025 |
| Macquarie | Analyst unavailable | $172 | $163.17 | +8.7% | Nov 25, 2025 |
| D.A. Davidson | Gil Luria | $250 | $190.25 | +58.0% | Oct 30, 2025 |
| BMO Capital | Keith Bachman | $230 | $191.23 | +45.4% | Oct 30, 2025 |
| UBS | Karl Keirstead | $230 | $182.34 | +45.4% | Oct 30, 2025 |
| RBC Capital | Matthew Hedberg | $240 | $190.21 | +51.7% | Oct 30, 2025 |
| Piper Sandler | Rob Owens | $230 | $189.32 | +45.4% | Oct 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $230 | $182.34 | +45.4% | Oct 30, 2025 |
| Morgan Stanley | Analyst unavailable | $263 | $182.34 | +66.3% | Oct 30, 2025 |
| Mizuho Securities | Analyst unavailable | $230 | $182.34 | +45.4% | Oct 30, 2025 |
| Bernstein | Analyst unavailable | $218.6 | $182.34 | +38.2% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $245 | $182.34 | +54.9% | Oct 30, 2025 |
| Wells Fargo | Analyst unavailable | $255 | $182.34 | +61.2% | Oct 30, 2025 |
| Goldman Sachs | Kash Rangan | $250 | $182.34 | +58.0% | Oct 30, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $240 | $186.03 | +51.7% | Oct 27, 2025 |
| UBS | Karl Keirstead | $215 | $184.74 | +35.9% | Oct 14, 2025 |
| Barclays | Raimo Lenschow | $242 | $199.24 | +53.0% | Jul 24, 2025 |
| Scotiabank | Allan Verkhovski | $220 | $193.05 | +39.1% | May 7, 2025 |
| Barclays | Raimo Lenschow | $217 | $193.05 | +37.2% | May 7, 2025 |
| UBS | Karl Keirstead | $205 | $186.9 | +29.6% | Apr 24, 2025 |
| Stifel Nicolaus | Brad Reback | $195 | $187.24 | +23.3% | Apr 24, 2025 |
| Bernstein | Peter Weed | $200.6 | $186.67 | +26.8% | Apr 24, 2025 |
| Barclays | Raimo Lenschow | $193.8 | $162.54 | +22.5% | Apr 24, 2025 |
| BMO Capital | Analyst unavailable | $190 | $153.37 | +20.1% | Apr 22, 2025 |
| Jefferies | Samad Samana | $205 | $159.96 | +29.6% | Apr 15, 2025 |
| BMO Capital | Analyst unavailable | $198 | $144.33 | +25.2% | Apr 4, 2025 |
| Robert W. Baird | Rob Oliver | $202 | $168.15 | +27.7% | Mar 26, 2025 |
| RBC Capital | Analyst unavailable | $197.2 | $161.68 | +24.7% | Mar 11, 2025 |
| UBS | Karl Keirstead | $200 | $161.68 | +26.4% | Mar 11, 2025 |
| Stifel Nicolaus | Brad Reback | $235 | $212.2 | +48.6% | Dec 18, 2024 |
| J.P. Morgan | Mark Murphy | $190 | $194.4 | +20.1% | Oct 24, 2024 |
| KeyBanc | Jackson Ader | $208 | $181.54 | +31.5% | Oct 24, 2024 |
| Piper Sandler | Rob Owens | $200 | $191.66 | +26.4% | Oct 24, 2024 |
| Stifel Nicolaus | Brad Reback | $198 | $191.87 | +25.2% | Oct 24, 2024 |
| Robert W. Baird | Rob Oliver | $195 | $181.54 | +23.3% | Oct 24, 2024 |
| RBC Capital | Matthew Hedberg | $209 | $181.54 | +32.1% | Oct 24, 2024 |
| Canaccord Genuity | Richard Davis | $200 | $181.54 | +26.4% | Oct 24, 2024 |
| Goldman Sachs | Kash Rangan | $210 | $181.54 | +32.8% | Oct 24, 2024 |
| Morgan Stanley | Keith Weiss | $192 | $184.35 | +21.4% | Oct 21, 2024 |
| Oppenheimer | Brian Schwartz | $204 | $183.77 | +29.0% | Oct 17, 2024 |
| Citigroup | Tyler Radke | $213.6 | $183.77 | +35.0% | Oct 17, 2024 |
| Jefferies | Samad Samana | $220 | $185.59 | +39.1% | Oct 16, 2024 |
| Barclays | Raimo Lenschow | $196 | $188.93 | +23.9% | Oct 11, 2024 |
| Bernstein | Peter Weed | $181.2 | $176.36 | +14.6% | Sep 27, 2024 |
| RBC Capital | Matthew Hedberg | $176 | $165.76 | +11.3% | Jul 25, 2024 |
| BMO Capital | Keith Bachman | $172 | $165.46 | +8.7% | Jul 25, 2024 |
| Stifel Nicolaus | Brad Reback | $180 | $146.17 | +13.8% | Jul 25, 2024 |
| Canaccord Genuity | David Hynes | $170 | $146.17 | +7.5% | Jul 25, 2024 |
| Robert W. Baird | Rob Oliver | $180 | $146.17 | +13.8% | Jul 25, 2024 |
| Piper Sandler | Rob Owens | $170 | $146.17 | +7.5% | Jul 25, 2024 |
| Needham | Mike Cikos | $180 | $153.24 | +13.8% | Jul 8, 2024 |
| Oppenheimer | Brian Schwartz | $165 | $153.01 | +4.3% | May 20, 2024 |
| BMO Capital | Keith Bachman | $166 | $139.73 | +4.9% | Apr 25, 2024 |
| KeyBanc | Jackson Ader | $190 | $149.26 | +20.1% | Apr 25, 2024 |
| Bernstein | Peter Weed | $169.2 | $149.26 | +7.0% | Apr 25, 2024 |
| Wells Fargo | Michael Turrin | $180 | $147.16 | +13.8% | Apr 16, 2024 |
| Deutsche Bank | Brad Zelnick | $175 | $153.84 | +10.6% | Apr 11, 2024 |
| KeyBanc | Jackson Ader | $200 | $153.51 | +26.4% | Mar 20, 2024 |
| Loop Capital Markets | Keith Bachman | $126 | $110.19 | -20.3% | Oct 26, 2023 |
| Needham | Mike Cikos | $132 | $112.99 | -16.6% | Jun 14, 2023 |
| Truist Financial | Analyst unavailable | $84 | $77.61 | -46.9% | Jan 9, 2023 |
| Piper Sandler | Analyst unavailable | $100 | $78.77 | -36.8% | Jan 5, 2023 |
| Morgan Stanley | Analyst unavailable | $122.4 | $76.41 | -22.6% | Dec 19, 2022 |
| Credit Suisse | Phil Winslow | $120 | $83.28 | -24.1% | Oct 27, 2022 |
| Morgan Stanley | Keith Weiss | $104 | $83.17 | -34.3% | Oct 27, 2022 |
| MoffettNathanson | Jackson Ader | $109.8 | $73.28 | -30.6% | Oct 27, 2022 |
| JMP Securities | Patrick Walravens | $110.6 | $73.28 | -30.1% | Oct 27, 2022 |
| Citigroup | Tyler Radke | $103 | $73.28 | -34.9% | Oct 27, 2022 |
| RBC Capital | Analyst unavailable | $110 | $87.56 | -30.5% | Jul 28, 2022 |
| Truist Financial | Analyst unavailable | $110 | $87.46 | -30.5% | Jul 28, 2022 |
| UBS | Analyst unavailable | $103 | $87.46 | -34.9% | Jul 28, 2022 |
| Cowen & Co. | Analyst unavailable | $116 | $87.46 | -26.7% | Jul 28, 2022 |
| Canaccord Genuity | Analyst unavailable | $102 | $87.46 | -35.5% | Jul 28, 2022 |
| Deutsche Bank | Analyst unavailable | $125 | $87.59 | -21.0% | Jul 28, 2022 |
| Stifel Nicolaus | Analyst unavailable | $100 | $89.72 | -36.8% | Jul 28, 2022 |
| Credit Suisse | Analyst unavailable | $130 | $89.72 | -17.8% | Jul 28, 2022 |
| Mizuho Securities | Analyst unavailable | $100 | $89.72 | -36.8% | Jul 28, 2022 |
| JMP Securities | Analyst unavailable | $110.6 | $89.72 | -30.1% | Jul 28, 2022 |
| Citigroup | Analyst unavailable | $115 | $89.72 | -27.3% | Jul 28, 2022 |
| Oppenheimer | Ray McDonough | $101 | $89.72 | -36.1% | Jul 28, 2022 |
| JMP Securities | Patrick Walravens | $110.6 | $89.72 | -30.1% | Jul 28, 2022 |
| BMO Capital | Keith Bachman | $99.4 | $89.72 | -37.2% | Jul 28, 2022 |
| Jefferies | Samad Samana | $100 | $89.72 | -36.8% | Jul 28, 2022 |
| Citigroup | Tyler Radke | $115 | $89.72 | -27.3% | Jul 28, 2022 |
| BMO Capital | Keith Bachman | $104 | $84.28 | -34.3% | Jul 26, 2022 |
| Morgan Stanley | Keith Weiss | $115 | $89.35 | -27.3% | Jul 25, 2022 |
| Cowen & Co. | Analyst unavailable | $118 | $90 | -25.4% | Jul 22, 2022 |
| Mizuho Securities | Analyst unavailable | $104 | $85.35 | -34.3% | Jul 19, 2022 |
| UBS | Analyst unavailable | $108 | $86.91 | -31.7% | Jul 18, 2022 |
| Barclays | Raimo Lenschow | $112 | $87.12 | -29.2% | Jul 18, 2022 |
| BMO Capital | Keith Bachman | $119 | $84.55 | -24.8% | Jul 14, 2022 |
| Stifel Nicolaus | Brad Reback | $110 | $93.5 | -30.5% | May 31, 2022 |
| Piper Sandler | Rob Owens | $120 | $90.96 | -24.1% | May 26, 2022 |
| Mizuho Securities | Analyst unavailable | $110 | $83.93 | -30.5% | May 25, 2022 |
| Jefferies | Analyst unavailable | $110 | $86.92 | -30.5% | May 23, 2022 |
| Wells Fargo | Michael Turrin | $120 | $87.2 | -24.1% | May 20, 2022 |
| Truist Financial | Joel Fishbein | $120 | $90.53 | -24.1% | May 14, 2022 |
| Deutsche Bank | Brad Zelnick | $136 | $96.9 | -14.0% | May 3, 2022 |
| Credit Suisse | Phil Winslow | $140 | $95.62 | -11.5% | Apr 30, 2022 |
| Morgan Stanley | Keith Weiss | $149 | $100.8 | -5.8% | Apr 28, 2022 |
| Barclays | Analyst unavailable | $122.6 | $100.74 | -22.5% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $134 | $98.72 | -15.3% | Apr 28, 2022 |
| Citigroup | Analyst unavailable | $131.2 | $93.26 | -17.1% | Apr 28, 2022 |
| RBC Capital | Matthew Hedberg | $134 | $100.8 | -15.3% | Apr 28, 2022 |
| Citigroup | Tyler Radke | $131.2 | $100.8 | -17.1% | Apr 28, 2022 |
| Robert W. Baird | Robert Oliver | $120 | $93.26 | -24.1% | Apr 28, 2022 |
| Evercore ISI | Kirk Materne | $142 | $100.8 | -10.2% | Apr 28, 2022 |
| BMO Capital | Analyst unavailable | $114 | $92.46 | -27.9% | Apr 27, 2022 |
| Jefferies | Samad Samana | $140 | $93.26 | -11.5% | Apr 27, 2022 |
| RBC Capital | Analyst unavailable | $132 | $94.28 | -16.6% | Apr 25, 2022 |
| Citigroup | Analyst unavailable | $124.6 | $103.67 | -21.2% | Apr 19, 2022 |
| Morgan Stanley | Keith Weiss | $162 | $112.22 | +2.4% | Jan 30, 2022 |
| Mizuho Securities | Gregg Moskowitz | $130 | $105.74 | -17.8% | Jan 27, 2022 |
| J.P. Morgan | Sterling Auty | $121 | $105.74 | -23.5% | Jan 27, 2022 |
| Credit Suisse | Philip Winslow | $160 | $105.74 | +1.2% | Jan 27, 2022 |
| BMO Capital | Keith Bachman | $127 | $105.74 | -19.7% | Jan 27, 2022 |
| Bank of America Securities | Bradley Sills | $136 | $105.74 | -14.0% | Jan 27, 2022 |
| Cowen & Co. | Derrick Wood | $145 | $105.74 | -8.3% | Jan 27, 2022 |
| Citigroup | Tyler Radke | $135 | $105.74 | -14.7% | Jan 27, 2022 |
| Deutsche Bank | Brad Zelnick | $140 | $96.88 | -11.5% | Jan 26, 2022 |
| RBC Capital | Matthew Hedberg | $140 | $105.17 | -11.5% | Jan 24, 2022 |
| UBS | Karl Keirstead | $130 | $103 | -17.8% | Jan 20, 2022 |
| Stifel Nicolaus | Tom Roderick | $130 | $104.47 | -17.8% | Jan 18, 2022 |
| Barclays | Raimo Lenschow | $136 | $106.2 | -14.0% | Jan 17, 2022 |
| Argus Research | Joseph Bonner | $161 | $137.32 | +1.8% | Nov 2, 2021 |
| Truist Financial | Joel Fishbein | $140 | $137.54 | -11.5% | Oct 28, 2021 |
| Goldman Sachs | Kash Rangan | $160 | $137.54 | +1.2% | Oct 28, 2021 |
| FBN Securities | Shebly Seyrafi | $140 | $137.54 | -11.5% | Oct 28, 2021 |
| Summit Redstone Partners | Srini Nandury | $150 | $137.54 | -5.2% | Oct 28, 2021 |
| KeyBanc | Michael Turits | $153 | $137.54 | -3.3% | Oct 28, 2021 |
| Evercore ISI | Kirk Materne | $147 | $135.34 | -7.1% | Oct 26, 2021 |
| Wolfe Research | Alex Zukin | $120 | $92.13 | -24.1% | Jun 4, 2021 |
Track every rating change on NOW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationServiceNow, Inc. specializes in delivering cloud-based solutions designed to streamline and automate critical business services for organizations across the globe. Its flagship "Now Platform" serves as the foundation, leveraging technologies such as workflow automation, artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA). This platform also incorporates robust features like performance analytics, electronic service catalogs, configuration management systems, data benchmarking, encryption capabilities, and various collaboration and development tools. ServiceNow offers a comprehensive suite of applications built on this platform, catering to diverse enterprise needs. Key offerings include IT Service Management (ITSM), which streamlines support for employees, customers, and partners; IT Business Management (ITBM); IT Operations Management (ITOM), designed to integrate and manage both physical and cloud-based IT infrastructure; and IT Asset Management (ITAM) for automating asset lifecycles.…
Historical context
All NOW earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CDNS Cadence Design Systems, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.9% | +1.8% | Cadence raises 2026 outlook as AI tools and verification demand accelerate |
| INFY Infosys Limited | FY2027 Q2 · Calendar Q4 2026 | -4.8% | -6.6% | Infosys trims growth outlook as AI revenue and deal wins accelerate |
| SSNC SS&C Technologies Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | +2.8% | SS&C raises 2026 outlook as AI and tokenization support growth |
| ROP Roper Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1.7% | +9.7% | Roper raises DEPS outlook as AI adoption expands across portfolio |
| VRSN VeriSign, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.0% | -0.9% | VeriSign reports record registrations as renewal mix becomes a key watchpoint |
| TTMI TTM Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +16.8% | -27.7% | TTM Technologies Q3: Record Growth, Higher Investment, More Deal Risk |
Latest beats and misses
Who reports nextBeat on EPS
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
Missed on EPS
- KOFFY2026 Q3 · October 26, 2026-9.0% EPS-1.9% move
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
Get the NOW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-23T01:04:55.098446+00:00
- FN2 earnings calendar · 2026-07-28T01:23:15.070317+00:00
- Polygon adjusted daily market bars · 2026-07-29T01:00:57.846305+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T01:00:57.843597+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-07-29. For educational purposes only; not investment advice.